Chris Ogden
Director of Finance/CFO bei CYTOMX THERAPEUTICS, INC.
Vermögen: 186 795 $ am 31.03.2024
Profil
Chris Ogden is currently the Chief Financial & Accounting Officer at CytomX Therapeutics, Inc. He previously worked as the Chief Financial Officer-Diabetes Division at Eli Lilly & Co. and as the Chief Financial Officer & Treasurer at Lilly del Caribe, Inc. Mr. Ogden completed his undergraduate degree at Wabash College and holds an MBA from Harvard Business School.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
19.03.2024 | 85 686 ( 0,13% ) | 186 795 $ | 31.03.2024 |
Aktive Positionen von Chris Ogden
Unternehmen | Position | Beginn |
---|---|---|
CYTOMX THERAPEUTICS, INC. | Director of Finance/CFO | 21.09.2022 |
Ehemalige bekannte Positionen von Chris Ogden
Unternehmen | Position | Ende |
---|---|---|
Lilly del Caribe, Inc.
Lilly del Caribe, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly del Caribe, Inc. is a Puerto Rican pharmaceutical manufacturing company. The private company is based in Mayagüez, Puerto Rico. | Director of Finance/CFO | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Ausbildung von Chris Ogden
Wabash College | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
CYTOMX THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Lilly del Caribe, Inc.
Lilly del Caribe, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly del Caribe, Inc. is a Puerto Rican pharmaceutical manufacturing company. The private company is based in Mayagüez, Puerto Rico. | Health Technology |